There is growing evidence that VEGF levels are elevated in the vitreous and subretinal fluid of eyes affected by Coats disease therefore Anti-VEGF therapy is effective in promoting the regression of abnormal vessels [1,3]. This evidence concerns the gene VEGFA and Coats disease.